EATG » News

The EATG endorses Life4me+ organisation and app

The European AIDS Treatment Group and Life4me.plus to fight AIDS, Hepatitis C and Tuberculosis have agreed to a mutual endorsement as partners.   Life4me+ is a community-based non-profit organisation, which…

The European AIDS Treatment Group names new Executive Director

The European AIDS Treatment Group (EATG) is delighted to introduce our new Executive Director, Pieter Vanholder. Pieter has a background in human rights and law and over a decade of…

#EU4Health: An overarching EU SDG implementation strategy is the only viable scenario

The European AIDS Treatment Group has co-signed a reaction letter to the European Commission’s Reflection Paper: Towards a Sustainable Europe by 2030, together with organisations that have endorsed the #EU4Health…

The EATG urges the Romanian government to adopt and implement the 2019-2021 HIV/AIDS National Strategic Plan

BRUSSELS - Today the European AIDS Treatment Group addresses a letter to the Romanian government in view of the new HIV/AIDS National Strategic Plan. In support of the demands and…

ОТЧЕТ ПО ДОСТУПУ К УСЛУГАМ, ОКАЗЫВАЕМЫМ ПРИ ВИРУСНОМ ГЕПАТИТЕ С, В МЕСТАХ ЛИШЕНИЯ СВОБОДЫ В ЕВРОПЕ ТЕПЕРЬ ЕСТЬ И НА РУССКОМ ЯЗЫКЕ – The report on access to HCV-related services in prison settings in Europe is now available in Russian

Отчет по доступу к услугам, оказываемым при вирусном гепатите С, в местах лишения свободы в Европе теперь есть и на русском языке. Несколько месяцев назад EATG опубликовала этот отчет и…

HepHIV2019: Meeting on implementing HIV, HBV and HCV testing guidance in the real world

In the frame of the HepHIV2019 conference taking place next week in Bucharest (28-30 January), the European AIDS Treatment Group and EuroTEST (formerly HIV in Europe) are co-hosting a multi-stakeholder breakfast…

Call for applications: Continuous Patient Education (CoPE) new call opens

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on how to apply for this grant. The submission deadline is 11…

The EATG publishes its position paper on sex work policy

Today, on the occasion of the International Day to End Violence Against Sex Workers, the European AIDS Treatment Group publishes its stand on the sex work policy debate and approaches…

Vieillir avec le VIH: Brussels-based organisations met to discuss about ageing with HIV

This week the European AIDS Treatment Group participated in a meeting on “Ageing with HIV: What challenges? What ways forward?”, organised by two francophone organisations based in Brussels that work…

The European AIDS Treatment Group supports the petition towards the next Global Fund Replenishment Conference

Ahead of the next conference to replenish the Global Fund in October 2019 in France, AIDES -together with collaborating organisations (Action Santé Mondiale / Global Health Advocates, Coalition PLUS, Équilibres & Populations, Médecins du…

Reporting from the 2nd Hep-C Community Summit (Lisbon, 18 September 2018)

The Hep-C Community Summit, organised by Correlation European Harm Reduction Network, has brought together people from the affected communities, advocates, researchers, healthcare providers, harm reduction practitioners, and policymakers to discuss…

EHVA: European HIV advocates discuss about new clinical study aiming to evaluate experimental strategies for the control of HIV infection

On Thursday, 15th of November, the European AIDS Treatment Group hosted a meeting with members of HIV organisations from six European countries to discuss the launch of the study EHVA…

HIV Outcomes: Online Compendium of Good Practices for the long-term health of people living with HIV launched

BRUSSELS: Today, HIV Outcomes launched an Online Compendium of Good Practices for securing the long-term health and well-being of people living with HIV.   Although people with HIV can now anticipate…

EmERGE: Community Meeting for the Last Phase of the Project (Madrid – November 7 2018)

The EmERGE project (about developing a mHealth platform for self-management of HIV and reducing face-to-face consultations), funded by the European Commission, has started its last 18 months. The European AIDS…

14 Patient Organisations Call for Meaningful Involvement in European Cooperation on Health Technology Assessment (HTA)

Today, 14 European patient organisations & federations have launched a statement calling on European institutions to adopt appropriate measures to fully incorporate meaningful involvement of patients in EU cooperation on…

The EATG publishes its position paper on drugs policy

Today, on the occasion of the joint meeting of the EU Civil Society Forum on HIV, Hepatitis and TB and the EU Civil Society Forum on Drugs, the European AIDS…

The EATG in the Civil Society Fora joint meetings (Brussels 6-8 November)

From 6-8 November, the EATG will be actively engaged in developing joint advocacy, sharing with and learning from civil society partners across Europe within the EU Civil Society Forum  on…

HIV Drug Therapy 2018 Congress – Quality of Life Across Different Age Groups of People Living with HIV: A Community Perspective

The European AIDS Treatment Group had the opportunity to co-organise and co-chair the ‘Quality of Life Across Different Age Groups of PLHIV: A Community Perspective’ session during this year's HIV Drug Therapy…

STEPS V: HIV CURE COMMUNITY WORKSHOP IN GLASGOW

STEPS, a community initiative to design the pathway to a long-term remission of HIV infection, has reached its 5th edition in Glasgow. This year the theme of the meeting that was held…

HIV Outcomes meeting: Improving long-term health and well-being of people living with HIV (Brussels – 27 November 2018)

One year after the launch of policy recommendations in the European Parliament, the HIV Outcomes initiative returns with an event to launch a "virtual good practice clinic" on chronic HIV…

Undetectable equals Untransmittable

Antiretroviral therapy (ART) has advanced consider­ably, from the approval of zidovudine (AZT) in 1987 through the emergence of triple-drug therapy and single-tablet regimens.1,2 Newer agents have fewer adverse effects and…

Smoking cannabis is an independent risk factor for lung disease in people with HIV

Frequent cannabis smoking is a risk factor for lung disease in HIV-positive men, according to US research published in EClinicalMedicine. Smoking cannabis increased the risk of pulmonary diseases – especially…

Changes in waist circumference in people taking ART

One of the undesirable potential side effects of taking antiretroviral therapy (ART) drugs can be weight gain. In a new study, a team of investigators looked at data from a…

Better physician-patient relationship reduces hospital readmissions for PLWHIV

Readmission within 30 days of discharge from the hospital is associated with adverse health outcomes, and the 30-day readmission rate serves as an important barometer of a hospital's quality of…

Novel method clears hepatitis C from donor lungs

A newly developed method of inactivating hepatitis C virus (HCV) in donor lungs has the potential to increase transplantations for patients with end stage lung disease without necessitating post-transplant antiviral…

Safe Consumption Sites: Study Identifies Policy Change Strategies and Challenges

NIH clinical trial to track outcomes of liver transplantation from HIV-positive donors to HIV-positive recipients

While the NHS drags its heels on PrEP, this is how men are being affected

40% of NHS clinics offering the drug in England are now turning away gay and bisexual men. Read the full article here.  

HIV prevention cascades could highlight gaps in prevention programmes

A simple HIV prevention cascade could be a powerful tool for advocates, policy makers and funders, researchers argue in Lancet HIV. It could help us understand where the gaps in prevention…

Engineered immune cells produce antibodies to fight HIV

Cells removed from patients’ bloodstreams and genetically altered may allow more effective vaccines for HIV, influenza, hepatitis LA JOLLA, CA, February 12, 2019 — Scripps Research scientists have successfully re-engineered human B…

High risk for virologic failure with dolutegravir monotherapy in chronic HIV

As a result of the high risk for virologic failure and for the emergence of integrase strand transfer inhibitor (INSTI) resistance, dolutegravir monotherapy should be avoided as a maintenance strategy…

Early ART in HIV possible key to dolutegravir monotherapy success

Dolutegravir monotherapy was noninferior to combination antiretroviral therapy (cART) in patients who started cART during primary HIV infection and were virologically suppressed for >48 weeks, according to study results published…

Russian court rules HIV-positive woman can adopt child

In a reported first for Russia, a court outside Moscow has allowed an HIV-positive woman to adopt a child. The ruling by a court in the city of Balashikha was…

Study shows increased mental health risk for Malawi children living with HIV

Almost one-third of children living with HIV in Malawi experienced emotional and behavioural difficulties, according to their primary caregivers in new research led by Curtin University. The research, published in…

Among injection drug users, HIV more prevalent in women than men

Study findings showed a higher prevalence of HIV among women who inject drugs compared with men, and researchers recommended developing gender-sensitive harm reduction services. According to the study, 20% of…

DPP-4 Inhibition Potentially Reduces Atherogenesis in Some People Living With HIV

Treatment with sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, had no effect on soluble CD14 when given to participants with virally suppressed HIV infection, according to findings published in Clinical Infectious Diseases. DPP4…

Countries use novel strategies to tackle price of HCV drugs

The introduction of direct-acting antivirals (DAAs) has changed the paradigm for treating hepatitis C virus (HCV) infections, with cure rates above 90%. The drawback is that these drugs come with…

Malaysia still under pressure to make hepatitis C medicine more expensive

The government of Malaysia continues to face pressure from the United States pharmaceutical industry and potentially the US government to undo an action taken to make a key hepatitis C…

Other hepatitis news

Hepatitis B Infectious Disease Advisor: Spontaneous loss of surface antigen infrequent in adults with chronic HBV infection Infectious Disease Advisor: Spontaneous loss of HBsAg uncommon in hepatitis B MD Magazine:…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 350 of the ‘Global Fund Observer.’ The newsletter includes articles…